Results 81 to 90 of about 1,610 (149)

Reply to Broomfield et al. Comment on "Jankovic et al. Understanding the Benefits of CO₂ Laser Treatment for Vulvovaginal Atrophy. <i>Medicina</i> 2024, <i>60</i>, 1059". [PDF]

Medicina (Kaunas)
Jankovic S, Rovcanin M, Tomic A, Jurisic A, Milovanovic Z, Zamurovic M.   +5 more
europepmc   +1 more source

Assessment of the Efficacy and Safety of a Dual-Wavelength Diode Laser System for the Treatment of Vulvovaginal Atrophy in Women Without a History of Breast Cancer and in Patients with a History of Breast Cancer. [PDF]

J Clin Med
Perrini G, Actis S, Giorgi M, Accomasso F, Minella C, Fava C, Bisconte G, De Rosa G, Ferrero A, Bounous VE.   +9 more
europepmc   +1 more source

Should I stay for local hormone therapy or should I go for radiofrequency to treat vulvovaginal atrophy? A patient preference trial. [PDF]

Menopause
Dell'Utri CM, Manzoni E, Bonfanti I, Marrocco F, Barbara G, Pifarotti P, Chiaffarino F.   +6 more
europepmc   +1 more source

Real‑world performance and safety of vaginal ovules in reducing the vaginal symptoms associated with vulvovaginal atrophy and postmenopausal sexual dysfunction. [PDF]

Biomed Rep
Iliescu DG, Petrita R, Teodorescu C, Olaru RA, Alexa AA, Petre I.   +5 more
europepmc   +1 more source

Study of Vulvovaginal Atrophy and Genitourinary Syndrome of Menopause and Its Impact on the Quality of Life of Postmenopausal Women in Central India. [PDF]

Cureus
Ulhe SC, Acharya N, Vats A, Singh A.
europepmc   +1 more source

Targeted therapy for vulvovaginal atrophy

Obstetrics and gynecology: News, Opinions, Training
O.P. Vinogradova, A.F. Shtakh, D.Yu. Bocharnikov, O.A. Biryuchkova, N.A. Mikhailova, M.S. Karaseva   +5 more
openaire   +1 more source

Vulvovaginal atrophy (VVA) in breast cancer survivors (BCS) is still an unmet medical need: results of an Italian Delphi Panel. [PDF]

Support Care Cancer, 2020
Biglia N, Del Pup L, Masetti R, Villa P, Nappi RE.   +4 more
europepmc   +1 more source

Safety and Efficacy of an Oxytocin Gel and an Equivalent Gel but Without Hormonal Ingredients (Vagivital^® Gel) in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy: A Randomized, Double-Blind Controlled Study. [PDF]

Med Devices (Auckl), 2020
Fianu Jonasson A, Bixo M, Sundström Poromaa I, Åstrom M, Åstrom M.   +4 more
europepmc   +1 more source

Effects of topical estrogen therapy on the vaginal microcirculation in women with vulvovaginal atrophy. [PDF]

Neurourol Urodyn, 2019
Diedrich CM, Kastelein AW, Verri FM, Weber MA, Ince C, Roovers JWR.   +5 more
europepmc   +1 more source

Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women. [PDF]

Front Endocrinol (Lausanne), 2019
Nappi RE, Martini E, Cucinella L, Martella S, Tiranini L, Inzoli A, Brambilla E, Bosoni D, Cassani C, Gardella B.   +9 more
europepmc   +1 more source